Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06795438

Effects of Green Tea on Cardiometabolic Outcomes

Effects of Green Tea Supplementation on Cardiometabolic Parameters

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Central Lancashire · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Green tea may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGreen teaGreen tea tablets 1000mg 1 x per day
OTHERPlaceboPlacebo control 1 x blinded placebo tablet per day

Timeline

Start date
2025-04-01
Primary completion
2027-02-01
Completion
2027-06-01
First posted
2025-01-28
Last updated
2025-03-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06795438. Inclusion in this directory is not an endorsement.